The regulation of mobile medical applications.

  title={The regulation of mobile medical applications.},
  author={A. Yetisen and J. L. Martinez-Hurtado and Fernando da Cruz Vasconcellos and M. C. E. Simsekler and M. S. Akram and C. R. Lowe},
  journal={Lab on a chip},
  volume={14 5},
  • A. Yetisen, J. L. Martinez-Hurtado, +3 authors C. R. Lowe
  • Published 2014
  • Medicine, Engineering
  • Lab on a chip
  • The rapidly expanding number of mobile medical applications have the potential to transform the patient-healthcare provider relationship by improving the turnaround time and reducing costs. In September 2013, the U.S. Food and Drug Administration (FDA) issued guidance to regulate these applications and protect consumers by minimising the risks associated with their unintended use. This guidance distinguishes between the subset of mobile medical apps which may be subject to regulation and those… CONTINUE READING

    Figures and Topics from this paper.

    Explore Further: Topics Discussed in This Paper

    mHealth and Mobile Medical Apps: A Framework to Assess Risk and Promote Safer Use
    • 161
    The Impact of Regulatory Changes on the Development of Mobile Medical Apps
    Mobile Medical Applications
    • 82
    • PDF
    Understanding the promises and premises of online health platforms
    • 61
    • PDF
    Threats and thrills: pregnancy apps, risk and consumption
    • 44
    • PDF


    Publications referenced by this paper.
    The regulation of mobile health applications
    • 135
    • PDF
    Mobile Tablet Use among Academic Physicians and Trainees
    • 114
    • PDF
    From the Food and Drug Administration.
    • 2,800
    • PDF